ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Abbott will pay $2.9 billion to acquire CFR Pharmaceuticals, a branded generic drug firm with headquarters in Santiago, Chile. Abbott says the acquisition will more than double its Latin American presence and place it among the top 10 drug companies in the region, where the pharmaceutical market tops $70 billion in annual sales. With operations in 15 Latin American countries, CFR will add about $900 million to Abbott’s annual sales in 2015. The acquisition also brings about 7,000 employees, and R&D and manufacturing facilities in Chile, Colombia, Peru, and Argentina.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter